COMORBIDITIES IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引:0
|
作者
Fu, A. Z. [1 ]
Zhao, Z. [2 ]
Wang, P. F. [2 ]
Barber, B. [2 ]
Liu, G. [3 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Peking Univ, Beijing 100871, Peoples R China
关键词
D O I
10.1016/S1098-3015(10)74260-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A257 / A257
页数:1
相关论文
共 50 条
  • [1] Comorbidities in patients with metastatic colorectal cancer (mCRC)
    Fu, A. Z.
    Zhao, Z.
    Wang, P. F.
    Barber, B.
    Liu, G. G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 339 - 339
  • [2] Cardiovascular Comorbidities among Patients with Metastatic Colorectal Cancer
    Overbeek, Jetty A.
    Zhao, Zhongyun
    van Herk-Sukel, Myrthe P. P.
    Barber, Beth L.
    Gao, Sue
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S277 - S278
  • [3] CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER
    Overbeek, J. A.
    Zhao, Z.
    van Herk-Sukel, M. P. P.
    Barber, B. L.
    Gao, S.
    Herings, R. M. C.
    VALUE IN HEALTH, 2011, 14 (03) : A155 - A155
  • [4] Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
    Amandine Gouverneur
    Clélia Favary
    Jérémy Jové
    Magali Rouyer
    Emmanuelle Bignon
    Francesco Salvo
    Achille Tchalla
    Elena Paillaud
    Thomas Aparicio
    Pernelle Noize
    Targeted Oncology, 2023, 18 : 717 - 726
  • [5] Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
    Gouverneur, Amandine
    Favary, Clelia
    Jove, Jeremy
    Rouyer, Magali
    Bignon, Emmanuelle
    Salvo, Francesco
    Tchalla, Achille
    Paillaud, Elena
    Aparicio, Thomas
    Noize, Pernelle
    TARGETED ONCOLOGY, 2023, 18 (05) : 717 - 726
  • [6] Association of multidimensional comorbidities with survival in elderly patients with metastatic colorectal cancer treated with chemotherapy
    Kim, Ki Hyang
    Lee, Jae Jin
    Kim, Jongphil
    Gomes, Fabio Renato Morgado
    Sehovic, Marina
    Extermann, Martine
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Impact of cardiovascular comorbidities on bevacizumab effectiveness and safety in older patients with metastatic colorectal cancer
    Noize, Pernelle
    Gouverneur, Amandine
    Favary, Clelia
    Jove, Jeremy
    Rouyer, Magali
    Bignon, Emmanuelle
    Salvo, Francesco
    Tchalla, Achille
    Paillaud, Elena
    Aparicio, Thomas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 375 - 375
  • [8] Impact of cardiovascular comorbidities on the effectiveness and safety of bevacizumab in older patients with metastatic colorectal cancer
    Gouverneur, A.
    Favary, C.
    Jove, J.
    Rouyer, M.
    Bignon, E.
    Tchalla, A.
    Paillaud, E.
    Aparicio, T.
    Noize, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 27 - 28
  • [9] Pre-existing comorbidities in patients with metastatic colorectal cancer receiving biologic treatments.
    Zhao, Z.
    Fu, A. Z.
    Barber, B.
    Gao, S. K.
    Liu, G. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Chemotherapy Use and Adoption of New Agents Is Affected by Age and Comorbidities in Patients With Metastatic Colorectal Cancer
    Vijayvergia, Namrata
    Li, Tianyu
    Wong, Yu-Ning
    Hall, Michael J.
    Cohen, Steven J.
    Dotan, Efrat
    CANCER, 2016, 122 (20) : 3191 - 3198